Ligands for Target Protein for PROTAC Ligands for Target Protein for PROTAC

Cat.No.	Name	Information
M57131	BTK ligand 1	BTK ligand 1 is a ligand targeting Bruton’s tyrosine kinase (Btk).
M57130	TSPO ligand-1	TSPO ligand-1 is the ligand of AUTAC4 that can be used in the synthesis of PROTACs.
M57129	PROTAC PTK6 ligand-1	PROTAC PTK6 ligand-1 is an intermediate for BTK kinase inhibitor preparation.
M57128	PROTAC BRD4 ligand-2	PROTAC BRD4 ligand-2 is a ligand for target BRD4 protein for PROTAC CFT-2718.
M57127	Abemaciclib metabolite M18	Abemaciclib metabolite M18 (LSN3106729), the metabolite of Abemaciclib, is a CDK inhibitor with antitumor activity.
M57126	PROTAC BET-binding moiety 2	PROTAC BET-binding moiety 2 is an inhibitor of BET bromodomain.
M57125	Dasatinib carbaldehyde	Dasatinib carbaldehyde (BMS-354825 carbaldehyde), the Dasatinib (ABL inhibitor) based moiety, binds to IAP ligand via a linker to form SNIPER .
M57124	PROTAC BET-binding moiety 1	PROTAC BET-binding moiety 1 is a key intermediate for the synthesis of high-affinity BET inhibitors.
M57123	PROTAC BRD9-binding moiety 1	PROTAC BRD9-binding moiety 1 is a compound that binds to BRD9, and used for inhibiting BRD9 activity, based on PROTAC.
M57122	Abemaciclib metabolite M18 hydrochloride	Abemaciclib metabolite M18 (LSN3106729) hydrochloride, the metabolite of Abemaciclib, is a CDK inhibitor with antitumor activity.
M57121	PROTAC BRD9-binding moiety 1 hydrochloride	PROTAC BRD9-binding moiety 1 hydrochloride is a compound that binds to BRD9, and used for inhibiting BRD9 activity, based on PROTAC.